Page last updated: 2024-08-24

aripiprazole and opc-14857

aripiprazole has been researched along with opc-14857 in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.38)	18.2507
2000's	15 (35.71)	29.6817
2010's	21 (50.00)	24.3611
2020's	5 (11.90)	2.80

Authors

Authors	Studies
Kikuchi, T; Kurahashi, N; Nishi, T; Oshiro, Y; Sato, S; Tanaka, T; Tottori, K; Uwahodo, Y	1
Bai, X; Chen, M; Chen, X; Frye, SV; Jin, J; Roth, BL; Sassano, MF; Setola, V; Wetsel, WC; Zheng, L	1
Handzlik, J; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Latacz, G; Lubelska, A; Partyka, A; Wesołowska, A	1
Hirao, Y; Kubo, M; Mizooku, Y; Osumi, T	1
Folnegović-Smalc, V; Kozumplik, O; Mimica, N; Uzun, S	1
Clarke, K; Davies, CH; Forbes, IT; Gribble, A; Hill, M; Jones, DN; Newson, M; Reavill, C; Rourke, C; Scott, C; Westaway, J; Wood, MD	1
Cho, JY; Jang, IJ; Kim, E; Kim, YY; Kwon, JS; Shin, SG; Shin, YW; Yoo, SY; Yu, KS	1
Lunde, H; Lunder, N; Molden, E; Refsum, H	1
Chiu, HJ; Hu, TM; Huang, HC; Lan, TH; Liu, CH; Tseng, YL; Wu, YC	1
Hendset, M; Hermann, M; Lunde, H; Molden, E; Refsum, H	1
Burchardt, C; Hiemke, C; Kirschbaum, KM; Malevani, J; Mobascher, A; Müller, MJ; Piel, M	1
Azuma, J; Fukuda, T; Koue, T; Kubo, M; Maune, H	1
Brovedani, S; Djebrani, K; Kraoul, L; Lancelin, F; Paubel, P; Piketty, ML; Tabaouti, K	1
Bachmann, CJ; Heinzel-Gutenbrunner, M; Hiemke, C; Remschmidt, H; Rieger-Gies, A; Theisen, FM	1
Wang, SJ; Yang, TT	1
Bahk, WM; Cho, JY; Jang, IJ; Kang, DH; Kim, JR; Kim, YK; Kwon, JS; Seo, HB; Shin, SG; Yu, KS	1
Hang, T; Song, M; Wen, A; Xu, X; Yang, L	1
Christensen, H; Hermann, M; Refsum, H; Rudberg, I; Waade, RB	1
Chang, CC; Chen, SH; Hwang, PL; Ko, JY; Wei, SY; Yeh, HH	1
Akamine, Y; Inoue, Y; Kojima, M; Uno, T; Yasui-Furukori, N	1
Arakaki, H; Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Ohta, I; Suzuki, T; Uno, T	1
Azuma, J; Fujiwara, T; Hara, S; Hasunuma, T; Higashi, K; Katano, T; Kitahara, S; Koue, T; Kubo, M; Miyatake, M	1
Forbes, RA; Kikuchi, T; McQuade, RD; Tadori, Y	1
Chen, CK; Lin, SK; Liu, YL	1
Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T	4
de Andrés, F; de la Rubia, A; Dorado, P; González, AP; González, I; Llerena, A; Naranjo, ME; Peñas-Lledó, EM	1
Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ	1
Caccia, F; Caloro, M; Cuomo, I; De Filippis, S; De Persis, S; Gentile, G; Girardi, P; Janiri, D; Kotzalidis, GD; Lionetto, L; Piazzi, G; Sciarretta, A; Simmaco, M; Simonetti, A; Telesforo, CL	1
Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ	1
Kawamura, A; Nagasaka, Y; Oda, K; Sano, T; Usui, T	1
Buckley, P; Corwin, MJ; Dretchen, K; McEvoy, J; Millet, RA; Morris, AA	1
Bond, M; Darwish, M; Hellriegel, ET; Robertson, P; Yang, R	1
Abad-Santos, F; Belmonte, C; Koller, D; Ochoa, D; Román, M; Ruiz-Nuño, A; Wojnicz, A	1
Goldnik, A; Mach, A; Malek, G; Marszalek, D; Pawinski, T; Somogi, A	1
Abad-Santos, F; Belmonte, C; Koller, D; Ochoa, D; Román, M; Saiz-Rodríguez, M; Zubiaur, P	1
Correll, CU; Høiseth, G; Molden, E; Smith, RL; Tveito, M	1
Banner, J; Johansen, SS; Linnet, K; Rygaard, K	1
Abad-Santos, F; Hempel, G; Kneller, LA; Koller, D; Zubiaur, P	1
An, H; Fan, H; Ma, B; Qi, S; Yang, F; Yun, Y; Zhao, W	1

Reviews

1 review(s) available for aripiprazole and opc-14857

Article	Year
Aripiprazole: an overview of a novel antipsychotic. Psychiatria Danubina, 2005, Volume: 17, Issue:1-2 Topics: Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Brain; Clinical Trials as Topic; Half-Life; Humans; Metabolic Clearance Rate; Piperazines; Psychotic Disorders; Quinolones; Receptors, Neurotransmitter; Treatment Outcome	2005

Trials

11 trial(s) available for aripiprazole and opc-14857

Article	Year
Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism. Drug metabolism and pharmacokinetics, 2007, Volume: 22, Issue:5 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Asian People; Biotransformation; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Homozygote; Humans; Japan; Phenotype; Piperazines; Polymorphism, Genetic; Quinolones; Reference Values; Tablets	2007
Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients. British journal of clinical pharmacology, 2008, Volume: 66, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Male; Mental Disorders; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperazines; Polymorphism, Genetic; Quinolones; Young Adult	2008
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. European journal of clinical pharmacology, 2012, Volume: 68, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluvoxamine; Genetic Association Studies; Half-Life; Humans; Japan; Male; Metabolic Clearance Rate; Paroxetine; Piperazines; Polymorphism, Genetic; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Young Adult	2012
Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Treatment Outcome	2011
Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2012, Volume: 34, Issue:2 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Basal Ganglia Diseases; Chromatography, Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Japan; Male; Mass Spectrometry; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Young Adult	2012
High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients. Drug metabolism and drug interactions, 2012, Volume: 27, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Limit of Detection; Male; Mental Disorders; Middle Aged; Piperazines; Quinolones; Reproducibility of Results; Spectrophotometry, Ultraviolet	2012
Intramuscular aripiprazole in the acute management of psychomotor agitation. Pharmacotherapy, 2013, Volume: 33, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Hospitals, University; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2013
Effects of escitalopram on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients. Pharmacopsychiatry, 2014, Volume: 47, Issue:3 Topics: Adult; Aripiprazole; Asian People; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Electrocardiography; Electroencephalography; Female; Genotype; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Piperazines; Quinolones	2014
Evaluation of Potential Pharmacokinetic Drug-Drug Interaction between Armodafinil and Aripiprazole in Healthy Adults. Pharmacopsychiatry, 2015, Volume: 48, Issue:4-5 Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Aripiprazole; Benzhydryl Compounds; Cytochrome P-450 CYP3A Inducers; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Modafinil; Piperazines; Quinolones; Wakefulness-Promoting Agents; Young Adult	2015
Prediction of an Optimal Dose of Aripiprazole in the Treatment of Schizophrenia From Plasma Concentrations of Aripiprazole Plus Its Active Metabolite Dehydroaripiprazole at Week 1. Therapeutic drug monitoring, 2017, Volume: 39, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nomograms; Piperazines; Quinolones; Schizophrenia; Time Factors; Treatment Outcome; Young Adult	2017
Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers. Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:3 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Circadian Rhythm; Cross-Over Studies; Cytochrome P-450 CYP2D6; Female; Humans; Ibuprofen; Male; Pharmacogenetics; Piperazines; Prolactin; Quinolones; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D3; Sex Factors; Young Adult	2020

Other Studies

30 other study(ies) available for aripiprazole and opc-14857

Article	Year
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives. Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5 Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Brain; Catalepsy; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine Antagonists; GABA Modulators; Male; Mice; Mice, Inbred ICR; Molecular Structure; Piperazines; Quinolones; Rats; Stereotyped Behavior; Structure-Activity Relationship	1998
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists. Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16 Topics: Animals; Antipsychotic Agents; Aripiprazole; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Female; HEK293 Cells; Humans; Hyperkinesis; Ligands; Male; Mice; Mice, Knockout; Phencyclidine; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship	2012
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT Bioorganic & medicinal chemistry letters, 2018, 03-01, Volume: 28, Issue:5 Topics: Dose-Response Relationship, Drug; Humans; Hydantoins; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship	2018
Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Aug-05, Volume: 822, Issue:1-2 Topics: Aripiprazole; Chromatography, Liquid; Drug Stability; Humans; Mass Spectrometry; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity	2005
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Binding, Competitive; Biotransformation; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; Male; Motor Activity; Oxidopamine; Piperazines; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Species Specificity; Transfection	2006
Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study. Human psychopharmacology, 2006, Volume: 21, Issue:8 Topics: Adult; Antipsychotic Agents; Area Under Curve; Aripiprazole; Cytochrome P-450 CYP2D6; Electroencephalography; Genotype; Half-Life; Humans; Male; Phenotype; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction	2006
Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients. Therapeutic drug monitoring, 2006, Volume: 28, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6 Inhibitors; Drug Monitoring; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Quinolones	2006
Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Sep-01, Volume: 856, Issue:1-2 Topics: Antipsychotic Agents; Aripiprazole; Gas Chromatography-Mass Spectrometry; Humans; Mental Disorders; Piperazines; Quinolones; Reference Standards; Sensitivity and Specificity	2007
Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole. European journal of clinical pharmacology, 2007, Volume: 63, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Piperazines; Quinolones; Retrospective Studies	2007
Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2008, Volume: 9, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Schizophrenia	2008
Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, May-01, Volume: 867, Issue:1 Topics: Adolescent; Adult; Aripiprazole; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	2008
Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia. Therapeutic drug monitoring, 2008, Volume: 30, Issue:4 Topics: Adolescent; Adult; Aging; Antipsychotic Agents; Aripiprazole; Biotransformation; Body Mass Index; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Piperazines; Quinolones; Regression Analysis; Schizophrenia; Sex Characteristics; Young Adult	2008
Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: possible relevance to neuroprotective interventions in schizophrenia. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:11 Topics: Animals; Aripiprazole; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Male; Neuroprotective Agents; Piperazines; Prefrontal Cortex; Presynaptic Terminals; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia	2008
Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma. Analytical biochemistry, 2009, Feb-15, Volume: 385, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Asian People; Chromatography, Liquid; Humans; Piperazines; Quinolones; Reproducibility of Results; Tandem Mass Spectrometry	2009
Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole. Therapeutic drug monitoring, 2009, Volume: 31, Issue:2 Topics: Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Induction; Enzyme Repression; Humans; Lithium Compounds; Piperazines; Quinolones; Trimeprazine	2009
Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia. Electrophoresis, 2010, Volume: 31, Issue:16 Topics: Adult; Amlodipine; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Electrophoresis, Capillary; Female; Humans; Hydrogen-Ion Concentration; Male; Piperazines; Quinolones; Reference Values; Schizophrenia; Solvents	2010
A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies. Journal of separation science, 2010, Volume: 33, Issue:21 Topics: Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Humans; Male; Molecular Structure; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Young Adult	2010
Effects of the CYP2D610 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2011, Volume: 33, Issue:1* Topics: Alleles; Antipsychotic Agents; Aripiprazole; Asian People; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Genotype; Humans; Male; Piperazines; Quinolones; Schizophrenia	2011
In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. European journal of pharmacology, 2011, Oct-15, Volume: 668, Issue:3 Topics: Animals; Aripiprazole; CHO Cells; Clozapine; Cricetinae; Cricetulus; Cyclic AMP; Dopamine; Drug Partial Agonism; Humans; Organic Chemicals; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Substrate Specificity	2011
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3 Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry	2013
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum. Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3 Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry	2013
Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole. Xenobiotica; the fate of foreign compounds in biological systems, 2014, Volume: 44, Issue:10 Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biotransformation; Brain Chemistry; Injections, Intravenous; Mice; Piperazines; Quinolones	2014
Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. Therapeutic drug monitoring, 2014, Volume: 36, Issue:5 Topics: Adult; Antipsychotic Agents; Aripiprazole; Asian People; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Male; Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Schizophrenia; Young Adult	2014
Quantitative levels of aripiprazole parent drug and metabolites in urine. Psychopharmacology, 2014, Volume: 231, Issue:23 Topics: Adult; Aripiprazole; Humans; Middle Aged; Piperazines; Prospective Studies; Quinolones; Substance Abuse Detection	2014
Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis, 2018, Mar-20, Volume: 151 Topics: Aripiprazole; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Phospholipids; Piperazines; Quinolones; Solid Phase Extraction; Tandem Mass Spectrometry	2018
SIMULTANEOUS ASSAY OF ARIPIPRAZOLE AND ITS ACTIVE METABOLITE IN SERUM BY HPLC. Acta poloniae pharmaceutica, 2017, Volume: 74, Issue:2 Topics: Acetonitriles; Activation, Metabolic; Antipsychotic Agents; Aripiprazole; Buffers; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Compounding; Drug Monitoring; Humans; Hydrogen-Ion Concentration; Phosphoric Acids; Piperazines; Quinolones; Schizophrenia; Solvents; Water	2017
Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status. European journal of clinical pharmacology, 2020, Volume: 76, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aripiprazole; Child; Cytochrome P-450 CYP2D6; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Sex Factors	2020
Concentrations of aripiprazole and dehydroaripiprazole in hair segments from deceased individuals with mental disorders. Forensic science international, 2020, Volume: 317 Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Forensic Toxicology; Hair; Humans; Male; Mental Disorders; Middle Aged; Piperazines; Polypharmacy; Postmortem Changes; Quinolones; Tandem Mass Spectrometry; Young Adult	2020
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach. Clinical pharmacokinetics, 2021, Volume: 60, Issue:12 Topics: Antipsychotic Agents; Aripiprazole; Cytochrome P-450 CYP2D6; Genotype; Humans; Phenotype; Piperazines; Quinolones	2021
Relationship Between Plasma Aripiprazole and Dehydroaripiprazole Concentrations and Prolactin Levels in Chinese Children and Adolescents. Journal of child and adolescent psychopharmacology, 2023, Volume: 33, Issue:1 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Cross-Sectional Studies; East Asian People; Female; Humans; Male; Prolactin; Retrospective Studies	2023